EP1215135A1 - Bottle for photosensitive dyes - Google Patents
Bottle for photosensitive dyes Download PDFInfo
- Publication number
- EP1215135A1 EP1215135A1 EP01430036A EP01430036A EP1215135A1 EP 1215135 A1 EP1215135 A1 EP 1215135A1 EP 01430036 A EP01430036 A EP 01430036A EP 01430036 A EP01430036 A EP 01430036A EP 1215135 A1 EP1215135 A1 EP 1215135A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- bottle
- phycoerythrin
- radiation
- visible
- fluorochromes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/24—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants
- B65D81/30—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants by excluding light or other outside radiation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
- Y10T428/131—Glass, ceramic, or sintered, fused, fired, or calcined metal oxide or metal carbide containing [e.g., porcelain, brick, cement, etc.]
- Y10T428/1317—Multilayer [continuous layer]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
- Y10T428/131—Glass, ceramic, or sintered, fused, fired, or calcined metal oxide or metal carbide containing [e.g., porcelain, brick, cement, etc.]
- Y10T428/1317—Multilayer [continuous layer]
- Y10T428/1321—Polymer or resin containing [i.e., natural or synthetic]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
- Y10T428/1352—Polymer or resin containing [i.e., natural or synthetic]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
- Y10T428/1352—Polymer or resin containing [i.e., natural or synthetic]
- Y10T428/139—Open-ended, self-supporting conduit, cylinder, or tube-type article
- Y10T428/1393—Multilayer [continuous layer]
Definitions
- the present invention relates to new packaging for photosensitive dyes and a new method of packaging fluorochromatic reagents for cytometry.
- Flow cytometry is a very specific cell analysis technique used for decades. This technique involves at least one fluorochrome.
- the main fluorochromes used in cytometry are fluorescein isothiocyanate (FITC), phycoerythrin (PE), allophycocyanin (APC), PercP, tandems phycoerythrin-cyanine 5 (PC5), phycoerythrin-cyanine 7 (PC7) and phycoerythrin-texas red (ECD or PETR).
- FITC fluorescein isothiocyanate
- PE phycoerythrin
- APC allophycocyanin
- PercP PercP
- PC5 phycoerythrin-cyanine 5
- PC7 phycoerythrin-cyanine 7
- ECD or PETR phycoerythrin-texas red
- the tandems PC5, PC7, ECD use the principle of transfer of energy, i.e. the laser of the cytometer excites the molecule in the area spectral of phycoerythrin which restores the energy absorbed to the molecule acceptor (cyanine 5, cyanine 7 or Texas red) which will return it itself in radiative form at its emission wavelength.
- the laser of the cytometer excites the molecule in the area spectral of phycoerythrin which restores the energy absorbed to the molecule acceptor (cyanine 5, cyanine 7 or Texas red) which will return it itself in radiative form at its emission wavelength.
- Tandem dyes nevertheless absorb light throughout spectral zone and particularly in the visible zone (400-800 nm) and the Applicant has realized that these fluorochromes, alone or in tandem, were subject to significant degradation during their conservation.
- tandem phycoerythrin-allophycocyanin has been described for some time 20 years (Glazer et al. Biophys. J. (1983) 83, 383-386 and the tandems phycoerythrin-cyanine 5 for almost 10 years Lanier et al. Methods (1991) Vol 2 N ° 3 192-199. Since then, this kind of product has been marketed in bottles of brown or amber glass by BECTON DICKINSON Companies, PHARMINGEN, DAKO, IQP, or CALTAG.
- the invention is based on the use of bottles opaque to radiation bright tandem exciters, i.e. between 200 and 900 nm and more particularly between 400 and 800 nm.
- the present request relates to packaging.
- Fluorochrome sensitive to visible light means a fluorochrome whose structure is degraded by emission at the indicated wavelengths, by example fluorescein isothiocyanate (FITC), phycoerythrin (PE), allophycocyanin (APC), PercP, phycoerythrin-cyanine tandems 7 (PC7), phycoerythrin-cyanine 5 (PC5) and phycoerythrin-texas red (ECD or PETR), preferably the latter two.
- FITC fluorescein isothiocyanate
- PE phycoerythrin
- APC allophycocyanin
- PercP phycoerythrin-cyanine tandems 7
- PC5 phycoerythrin-cyanine 5
- ECD or PETR phycoerythrin-texas red
- the terms “form an effective screen radiation” means that at least 95%, preferably at least 98%, particularly at least 99% and especially 100% of radiation from visible are stopped by the side walls of the bottle due to their structure (nature, treatment or sheathing in particular).
- the term “bottle” refers to preferably a small bottle preferably with a screw, fitted with a cap with or without septum.
- the bottle can be made of polyethylene, polypropylene, polycarbonate, but preferably glass. Its capacity can preferably range from 50 ⁇ l to 50 ml, especially from 100 ⁇ l to 20 ml, especially from 500 ⁇ l to 10 ml and all especially from 1 ml to 10 ml. For example, a 5 ml bottle can be filled per 1 to 2 ml of solution.
- glass vials of about 5 ml.
- the bottom of the bottle also forms an effective radiation shield visible.
- Sheathing techniques are already known in perfumery or coating of vials forming an effective shield against spectrum radiation visible, used for aesthetic purposes.
- Examples include powder coating electrostatic which consists in surrounding the bottles with a septum which is pierced by an electrode which is installed in the bottle to be covered.
- the vials are placed in an enclosure containing a powder sprayed, charged with a sign opposite to that of the bottle.
- the powder is deposited then on the bottle on which it is fixed for example by cooking in an oven at around 180 ° C.
- a epoxy resin powder preferably absorbing in the wavelengths above indicated, particularly 600 to 800 nanometers, black or blue in particular.
- the packaging object of the present invention have very interesting properties.
- the use of covered or treated bottles as described above eliminates the photoinduced oxidation phenomenon and provides excellent stability to fluorochromes-antibody conjugates or Tandem-antibodies.
- the present invention also applies to other conjugates antibody-tandems than those mentioned above, as well as all fluorochromes used in flow cytometry.
- the present application also relates to a method for protecting fluorochromes sensitive to visible light and particularly to lengths wave ranging from 400 to 600 nanometers during their conservation, in which installs said fluorochromes in a bottle with at least the side walls have a structure that forms an effective screen for radiation from the light spectrum between 200 and 800 nm, particularly at wavelengths ranging from 400 to 800 nanometers, more particularly from 400 to 700 nanometers and particularly between 400 and 600 nm.
- Example 1 Coating of a glass bottle with epoxy resin
- Example 3 Manufacture of a glass vial covered with epoxy resin filled with a solution of anti-CD3-Phycoerythrin-cyanine antibody conjugates in PBS, BSA 2 mg / ml, sodium azide 0.1%.
- Vials made according to Example 1 were filled with each 2 ml solution of anti-CD3-Phycoerythrin-cyanine antibody conjugates 5 in phosphate buffer / bovine serum albumin (2 mg / ml) / azide 0.1% sodium.
- flasks commercial and modified products containing anti-CD3 antibodies conjugated to PC5 and ECD fluorochromes underwent a forced degradation test according to the method described in good manufacturing practices (Good Manufacturing Practice (GMP)) of the US Food and Drug Administration.
- GMP Good Manufacturing Practice
- Figure 1 shows the excellent protection of the contents of the vials in implementing the invention.
- the tandems introduced in the bottle BeckmanCoulter Immunotech from the IOTEST range covered with a layer of epoxy varnish according to the electrostatic powdering process have a autofluorescence in FL2 identical to that of the non-irradiated control.
- all the other types of bottles show a light permeability which is translated by a "leak" in FL2, ie an increase in autofluorescence with the appearance of false positive cells.
Landscapes
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Mechanical Engineering (AREA)
- Packages (AREA)
- Silver Salt Photography Or Processing Solution Therefor (AREA)
- Treatments Of Macromolecular Shaped Articles (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Description
La présente invention concerne de nouveaux conditionnements pour colorants photosensibles et une nouvelle méthode de conditionnement de réactifs à base de fluorochromes pour la cytométrie.The present invention relates to new packaging for photosensitive dyes and a new method of packaging fluorochromatic reagents for cytometry.
La cytométrie de flux est une technique d'analyse de cellules très utilisée depuis des décennies. Cette technique met en jeu au moins un fluorochrome.Flow cytometry is a very specific cell analysis technique used for decades. This technique involves at least one fluorochrome.
C'est un outil puissant pour l'analyse antigénique cellulaire. Cette technique permet d'analyser plusieurs cibles antigéniques en même temps grâce à des combinaisons d'anticorps conjugués à des fluorochromes. Les principaux fluorochromes utilisés en cytométrie sont la fluorescéine isothiocyanate (FITC), la phycoérythrine (PE), l'allophycocyanine (APC), le PercP, les tandems phycoérythrine-cyanine 5 (PC5), phycoérythrine-cyanine 7 (PC7) et phycoérythrine-texas red (ECD ou PETR). Ces fluorochromes absorbent les radiations lumineuses particulièrement à 488 nm et 633 nm qui sont les principales longueurs d'ondes d'émission des lasers utilisés sur les cytomètres. Les tandems PC5, PC7, ECD utilisent le principe du transfert d'énergie, c'est à dire que le laser du cytomètre excite la molécule dans la zone spectrale de la phycoérythrine qui restitue l'énergie absorbée à la molécule accepteuse (cyanine 5, cyanine 7 ou Texas red) qui va elle même la restituer sous forme radiative à sa longueur d'onde d'émission.It is a powerful tool for cellular antigen analysis. This technique allows to analyze several antigenic targets at the same time thanks to combinations of antibodies conjugated to fluorochromes. The main fluorochromes used in cytometry are fluorescein isothiocyanate (FITC), phycoerythrin (PE), allophycocyanin (APC), PercP, tandems phycoerythrin-cyanine 5 (PC5), phycoerythrin-cyanine 7 (PC7) and phycoerythrin-texas red (ECD or PETR). These fluorochromes absorb light radiation particularly at 488 nm and 633 nm which are the main emission wavelengths of the lasers used on the cytometers. The tandems PC5, PC7, ECD use the principle of transfer of energy, i.e. the laser of the cytometer excites the molecule in the area spectral of phycoerythrin which restores the energy absorbed to the molecule acceptor (cyanine 5, cyanine 7 or Texas red) which will return it itself in radiative form at its emission wavelength.
Les colorants tandems absorbent néanmoins la lumière dans toute la zone spectrale et particulièrement dans la zone du visible (400-800 nm) et la demanderesse s'est rendue compte que ces fluorochromes, seuls ou en tandem, faisaient l'objet de dégradations sensibles pendant leur conservation.Tandem dyes nevertheless absorb light throughout spectral zone and particularly in the visible zone (400-800 nm) and the Applicant has realized that these fluorochromes, alone or in tandem, were subject to significant degradation during their conservation.
Ces dégradations induisent une détérioration de l'efficacité du transfert énergétique qui conduit à une augmentation de l'intensité de fluorescence de la phycoérythrine à 580 nm. Ce phénomène se traduit en cytométrie par une augmentation de fluorescence (appelée fuite) dans le canal de la phycoérythrine (FL2) pouvant conduire à différents problèmes :
- Apparition de cellules faussement positives
- Nécessité d'augmenter les compensations afin de retrouver les valeurs d'intensité de fluorescence initiales.
- Appearance of false positive cells
- Need to increase the compensations in order to find the initial fluorescence intensity values.
Le dernier point est particulièrement crucial dans le cas des systèmes informatiques de compensation automatique.The last point is particularly crucial in the case of automatic compensation computer systems.
Le tandem phycoérythrine-allophycocyanine a été décrit depuis près de 20 ans (Glazer et al. Biophys. J. (1983) 83, 383-386 et les tandems phycoérythrine-cyanine 5 depuis près de 10 ans Lanier et al. Methods (1991) Vol 2 N°3 192-199. Depuis, ce genre de produits est commercialisé dans des flacons de verre brun ou ambré par les Sociétés BECTON DICKINSON, PHARMINGEN, DAKO, IQP, ou CALTAG.The tandem phycoerythrin-allophycocyanin has been described for some time 20 years (Glazer et al. Biophys. J. (1983) 83, 383-386 and the tandems phycoerythrin-cyanine 5 for almost 10 years Lanier et al. Methods (1991) Vol 2 N ° 3 192-199. Since then, this kind of product has been marketed in bottles of brown or amber glass by BECTON DICKINSON Companies, PHARMINGEN, DAKO, IQP, or CALTAG.
Il serait donc souhaitable de disposer d'un conditionnement de fluorochromes assurant la conservation desdits fluorochromes pendant une durée prolongée.It would therefore be desirable to have a packaging of fluorochromes ensuring the conservation of said fluorochromes during a extended duration.
Après un certain nombre de tests, la demanderesse a émis l'hypothèse que ces fluorochromes pourraient être sensibles à la lumière visible. Elle a alors recouvert les parois latérales des flacons de fluorochromes d'une gaine thermorétractable absorbant la lumière visible. Une amélioration très sensible a alors été observée, ne donnant toutefois pas encore totale satisfaction. Elle a alors procédé à d'autres essais qui n'apportaient pas de progrès supplémentaire.After a number of tests, the applicant hypothesized that these fluorochromes could be sensitive to visible light. She then covered the side walls of the fluorochromes bottles with a sheath heat shrinkable absorbing visible light. A very noticeable improvement has then observed, however not yet giving complete satisfaction. She has then carried out other tests which did not bring any further progress.
En poursuivant encore ses recherches, la demanderesse a découvert avec étonnement que le fait que le fond des flacons gainés ne soit pas protégés suffisait à dégrader les fluorochromes, lorsque les flacons étaient manipulés ou renversés à plat sur leur côté au lieu d'être posés sur leur fond. Elle a alors compris que ces fluorochromes étaient très sensibles aux longueurs d'onde allant de 200 à 900 nanomètres, notamment à la lumière visible, particulièrement aux longueurs d'onde allant de 400 à 700 nanomètres et singulièrement aux longueurs d'onde allant de 400 à 600 nanomètres.While continuing her research, the plaintiff discovered with astonishment that the fact that the bottom of the sheathed bottles is not protected sufficient to degrade fluorochromes, when the bottles were handled or overturned flat on their side instead of being placed on their bottom. She then understood that these fluorochromes were very sensitive to wavelengths ranging from 200 to 900 nanometers, especially in visible light, particularly at wavelengths ranging from 400 to 700 nanometers and particularly at wavelengths ranging from 400 to 600 nanometers.
Selon la demanderesse, la dégradation des tandems aurait pour origine un phénomène d'oxydation photo induit dans lequel les molécules jouent le rôle de photo sensibilisateur, c'est à dire qu'elles sont capables d'activer l'oxygène :
- par transfert de l'énergie lumineuse absorbée avec génération d'oxygène singulet (mécanisme dit de type II),
- par transfert d'électron à l'état excité avec génération de radicaux oxygénés (mécanisme dit de type I).
- by transfer of the absorbed light energy with generation of singlet oxygen (so-called type II mechanism),
- by electron transfer in the excited state with generation of oxygen radicals (so-called type I mechanism).
L'invention repose sur l'utilisation de flacons opaques aux radiations lumineuses excitatrices des tandems, c'est à dire entre 200 et 900 nm et plus particulièrement entre 400 et 800 nm.The invention is based on the use of bottles opaque to radiation bright tandem exciters, i.e. between 200 and 900 nm and more particularly between 400 and 800 nm.
C'est pourquoi la présente demande a pour objet un conditionnement comprenant un fluorochrome sensible aux longueurs d'onde allant de 200 à 900 nanomètres et singulièrement aux longueurs d'onde allant de 400 à 600 nanomètres placé dans un flacon dont au moins les parois latérales forment un écran efficace aux radiations du spectre lumineux entre 200 et 900 nm, particulièrement aux longueurs d'onde allant de 400 à 800 nanomètres, plus particulièrement de 400 à 700 nanomètres et singulièrement entre 400 et 600 nm.This is why the present request relates to packaging. comprising a fluorochrome sensitive to wavelengths ranging from 200 to 900 nanometers and particularly at wavelengths ranging from 400 to 600 nanometers placed in a bottle of which at least the side walls form a screen effective at radiations of the light spectrum between 200 and 900 nm, particularly at wavelengths from 400 to 800 nanometers, more particularly from 400 to 700 nanometers and particularly between 400 and 600 nm.
Dans la présente demande et dans ce qui suit, les termes «fluorochrome sensible à la lumière visible» désignent un fluorochrome dont la structure est dégradée par une émission aux longueurs d'onde indiquée , par exemple la fluorescéine isothiocyanate (FITC), la phycoérythrine (PE), l'allophycocyanine (APC), le PercP, les tandems phycoérythrine-cyanine 7 (PC7), phycoérythrine-cyanine 5 (PC5) et phycoérythrine-texas red (ECD ou PETR), de préférence ces deux derniers. Les termes «forment un écran efficace aux radiations» signifient que au moins 95 %, de préférence au moins 98 %, particulièrement au moins 99 % et tout particulièrement 100% des radiations du visible sont stoppées par les parois latérales du flacon en raison de leur structure (nature, traitement ou gainage notamment). Le terme « flacon» désigne de préférence une petite bouteille de préférence à vis, équipée d'un bouchon avec ou sans septum. Le flacon peut être en polyéthylène, polypropylène, polycarbonate, mais de préférence en verre. Sa capacité peut aller de préférence de 50 µl à 50 ml, notamment de 100 µl à 20 ml, particulièrement de 500 µl à 10 ml et tout particulièrement de 1 ml à 10 ml. Un flacon de 5 ml peut par exemple être rempli par 1 à 2 ml de solution.In the present application and in the following, the terms "Fluorochrome sensitive to visible light" means a fluorochrome whose structure is degraded by emission at the indicated wavelengths, by example fluorescein isothiocyanate (FITC), phycoerythrin (PE), allophycocyanin (APC), PercP, phycoerythrin-cyanine tandems 7 (PC7), phycoerythrin-cyanine 5 (PC5) and phycoerythrin-texas red (ECD or PETR), preferably the latter two. The terms "form an effective screen radiation "means that at least 95%, preferably at least 98%, particularly at least 99% and especially 100% of radiation from visible are stopped by the side walls of the bottle due to their structure (nature, treatment or sheathing in particular). The term "bottle" refers to preferably a small bottle preferably with a screw, fitted with a cap with or without septum. The bottle can be made of polyethylene, polypropylene, polycarbonate, but preferably glass. Its capacity can preferably range from 50 µl to 50 ml, especially from 100 µl to 20 ml, especially from 500 µl to 10 ml and all especially from 1 ml to 10 ml. For example, a 5 ml bottle can be filled per 1 to 2 ml of solution.
On préfère tout particulièrement des flacons de verre de 5 ml environ.Particularly preferred are glass vials of about 5 ml.
Dans des conditions préférentielles de mise en oeuvre de l'invention, le fond du flacon forme également un écran efficace aux radiations du spectre visible. Under preferential conditions for implementing the invention, the bottom of the bottle also forms an effective radiation shield visible.
Il est déjà connu en parfumerie des techniques de gainage ou revêtement de flacons formant un écran efficace aux radiations du spectre visible, utilisées à des fins esthétiques.Sheathing techniques are already known in perfumery or coating of vials forming an effective shield against spectrum radiation visible, used for aesthetic purposes.
On peut citer par exemple le revêtement par poudrage électrostatique qui consiste à entourer les flacons d'un septum qui est transpercé par une électrode qui est installée dans le flacon à recouvrir. Les flacons sont placés dans une enceinte dans laquelle se trouve une poudre pulvérisée, chargée d'un signe opposé à celui du flacon. La poudre se dépose alors sur le flacon sur lequel elle est fixée par exemple par cuisson dans un four à environ 180°C. Dans le cadre de l'invention, on peut utiliser par exemple une poudre de résine époxy absorbant de préférence dans les longueurs d'ondes ci-dessus indiquées, particulièrement 600 à 800 nanomètres, de couleur noire ou bleue notamment.Examples include powder coating electrostatic which consists in surrounding the bottles with a septum which is pierced by an electrode which is installed in the bottle to be covered. The vials are placed in an enclosure containing a powder sprayed, charged with a sign opposite to that of the bottle. The powder is deposited then on the bottle on which it is fixed for example by cooking in an oven at around 180 ° C. In the context of the invention, it is possible, for example, to use a epoxy resin powder preferably absorbing in the wavelengths above indicated, particularly 600 to 800 nanometers, black or blue in particular.
On peut aussi gainer le flacon d'une gaine avantageusement thermorétractable recouvrant de préférence également le fond du flacon.You can also sheath the bottle with a sheath advantageously heat shrink preferably also covering the bottom of the bottle.
On peut encore irradier certains types de verres par rayonnement gamma.We can still irradiate certain types of glasses by radiation gamma.
On peut tout autant effectuer un surmoulage à l'aide d'un film plastique, ce qui offre l'avantage de pouvoir recouvrir le fond des flacons.It is just as possible to make a molding using a film plastic, which has the advantage of being able to cover the bottom of the bottles.
Les conditionnements objet de la présente invention possèdent de très intéressantes propriétés. L'utilisation de flaconnages recouverts ou traités comme décrit ci-dessus supprime le phénomène d'oxydation photoinduit et confère une excellente stabilité aux conjugués fluorochromes-anticorps ou tandems-anticorps.The packaging object of the present invention have very interesting properties. The use of covered or treated bottles as described above eliminates the photoinduced oxidation phenomenon and provides excellent stability to fluorochromes-antibody conjugates or Tandem-antibodies.
Ces propriétés sont illustrées ci-après dans la partie expérimentale.These properties are illustrated below in the experimental part.
La présente invention s'applique également aux autres conjugués anticorps-tandems que ceux cités ci-dessus, ainsi qu'à tous les fluorochromes utilisés en cytométrie en flux.The present invention also applies to other conjugates antibody-tandems than those mentioned above, as well as all fluorochromes used in flow cytometry.
La présente demande a aussi pour objet un procédé de protection de fluorochromes sensibles à la lumière visible et singulièrement aux longueurs d'onde allant de 400 à 600 nanomètres lors de leur conservation, dans lequel on installe lesdits fluorochromes dans un flacon dont au moins les parois latérales ont une structure qui forme un écran efficace aux radiations du spectre lumineux entre 200 et 800 nm, particulièrement aux longueurs d'onde allant de 400 à 800 nanomètres, plus particulièrement de 400 à 700 nanomètres et singulièrement entre 400 et 600 nm.The present application also relates to a method for protecting fluorochromes sensitive to visible light and particularly to lengths wave ranging from 400 to 600 nanometers during their conservation, in which installs said fluorochromes in a bottle with at least the side walls have a structure that forms an effective screen for radiation from the light spectrum between 200 and 800 nm, particularly at wavelengths ranging from 400 to 800 nanometers, more particularly from 400 to 700 nanometers and particularly between 400 and 600 nm.
Les conditions préférentielles de mise en oeuvre des conditionnements ci-dessus décrites s'appliquent également aux autres objets de l'invention visés ci-dessus, notamment au procédé de protection de fluorochromes.Preferential conditions for the implementation of packaging described above also apply to the other objects of the invention referred to above, in particular to the process for protecting fluorochromes.
Les exemples qui suivent illustrent la présente demande.
- les figures 1A, B, C, D et E représentent les résultats de fluorescence obtenus avec des échantillons de conjugués Anticorps anti-CD3-Phycoérythrine-cyanine 5 contenus dans leur flacon d'origine ou d'un flacon selon l'invention, et soumis à l'action de la lumière, et
- les figures 2A, B, C et D représentent les résultats de fluorescence obtenus avec des échantillons de conjugués Anticorps anti-CD19-Phycoérythrine-texas red contenus dans leur flacon d'origine ou d'un flacon selon l'invention, et soumis à l'action de la lumière.
- FIGS. 1A, B, C, D and E represent the fluorescence results obtained with samples of anti-CD3-Phycoerythrin-cyanine antibody conjugates contained in their original bottle or in a bottle according to the invention, and subjected to the action of light, and
- FIGS. 2A, B, C and D represent the fluorescence results obtained with samples of anti-CD19-Phycoerythrin-texas red antibody conjugates contained in their original bottle or in a bottle according to the invention, and subjected to l action of light.
Plus précisément,
- les figures 1A et 2A concernent un conjugué protégé de la lumière, servant de témoin,
- les figures 1B et 2B concernent un conjugué conditionné dans un flacon de verre commercial BeckmanCoulter Immunotech de la gamme IOTEST,
- les figures 1C et 2C concernent un conjugué conditionné dans un flacon de verre commercial BeckmanCoulter Immunotech de la gamme Cytostat,
- la figure 1D concerne un conjugué conditionné dans un flacon de verre commercial BECTON DICKINSON Pharmingen, et
- les figures 1E et 2D concernent un conjugué conditionné dans un flacon de verre commercial BeckmanCoulter Immunotech de la gamme IOTEST recouvert d'une couche de vernis époxy selon le procédé de poudrage électrostatique de l'exemple 1.
- FIGS. 1A and 2A relate to a conjugate protected from light, serving as a control,
- FIGS. 1B and 2B relate to a conjugate packaged in a BeckmanCoulter Immunotech commercial glass bottle from the IOTEST range,
- FIGS. 1C and 2C relate to a conjugate packaged in a BeckmanCoulter Immunotech commercial glass bottle from the Cytostat range,
- FIG. 1D relates to a conjugate packaged in a BECTON DICKINSON Pharmingen commercial glass bottle, and
- FIGS. 1E and 2D relate to a conjugate packaged in a BeckmanCoulter Immunotech commercial glass bottle from the IOTEST range covered with a layer of epoxy varnish according to the electrostatic powdering process of Example 1.
On place des flacons commerciaux en verre destinés à recevoir des
conjugués Anticorps anti-CD3-Phycoérythrine-cyanine 5 de BeckmanCoulter
Immunotech de la gamme IOTEST dans une chaíne mettant en oeuvre les
étapes suivantes :
On a recouvert les côtés et le col de flacons commerciaux de 6ml en verre destinés à recevoir des conjugués Anticorps anti-CD3-Phycoérythrine-cyanine 5 de Beckman Coulter Immunotech de la gamme IOTEST à l'aide de gaine thermo-rétractable de polyéthylène commercialisée par la société SLEEVER INTERNATIONAL.We covered the sides and the neck with 6ml commercial bottles in glass intended to receive anti-CD3-Phycoerythrin-cyanine antibody conjugates 5 of Beckman Coulter Immunotech from the IOTEST range using polyethylene heat-shrink tubing sold by the company SLEEVER INTERNATIONAL.
On a rempli des flacons fabriqués selon l'exemple 1 avec chacun 2 ml d'une solution de conjugués Anticorps anti-CD3-Phycoérythrine-cyanine 5 dans du tampon phosphate / sérum albumine bovine (2 mg/ml) / azoture de sodium 0,1%.Vials made according to Example 1 were filled with each 2 ml solution of anti-CD3-Phycoerythrin-cyanine antibody conjugates 5 in phosphate buffer / bovine serum albumin (2 mg / ml) / azide 0.1% sodium.
Afin de démontrer l'efficacité du procédé de l'invention, des flacons commerciaux et modifiés contenant des anticorps anti-CD3 conjugués à des fluorochromes PC5 et ECD ont subi un test de dégradation forcé selon la méthode décrite dans les bonnes pratiques de fabrication (Good Manufacturing Practice (GMP)) de la Food and Drug Administration américaine.In order to demonstrate the effectiveness of the process of the invention, flasks commercial and modified products containing anti-CD3 antibodies conjugated to PC5 and ECD fluorochromes underwent a forced degradation test according to the method described in good manufacturing practices (Good Manufacturing Practice (GMP)) of the US Food and Drug Administration.
Différents conditionnements ont été testés :
- Flacon commercial BeckmanCoulter Immunotech de la gamme IOTEST
- Flacon commercial BeckmanCoulter Immunotech de la gamme Cytostat
- Flacon commercial BeckmanCoulter Immunotech de la gamme IOTEST recouvert d'une couche de vernis époxy selon le procédé de poudrage électrostatique
- Flacon commercial BECTON DICKINSON Pharmingen.
- BeckmanCoulter Immunotech commercial bottle from the IOTEST range
- BeckmanCoulter Immunotech commercial bottle from the Cytostat range
- BeckmanCoulter Immunotech commercial bottle from the IOTEST range covered with a layer of epoxy varnish using the electrostatic powdering process
- BECTON DICKINSON Pharmingen commercial bottle.
Ces flacons contenant les conjugués anticorps-tandems ont été introduits dans une chambre équipée de tubes fluorescents et ont été soumis à une dose lumineuse totale de 1,2.106 lux.h.These bottles containing the antibody-tandem conjugates were introduced into a chamber equipped with fluorescent tubes and were subjected to a total light dose of 1.2 × 10 6 lux.h.
La figure 1 montre l'excellente protection du contenu des flacons en mettant en oeuvre l'invention. En effet les tandems introduits dans le flacon BeckmanCoulter Immunotech de la gamme IOTEST recouvert d'une couche de vernis époxy selon le procédé de poudrage électrostatique présentent une autofluorescence en FL2 identique à celle du témoin non irradié. En revanche tous les autres types de flaconnage montrent une perméabilité lumineuse qui se traduit par une « fuite » en FL2, c'est à dire une augmentation de l'autofluorescence avec apparition de cellules faussement positives.Figure 1 shows the excellent protection of the contents of the vials in implementing the invention. Indeed the tandems introduced in the bottle BeckmanCoulter Immunotech from the IOTEST range covered with a layer of epoxy varnish according to the electrostatic powdering process have a autofluorescence in FL2 identical to that of the non-irradiated control. On the other hand all the other types of bottles show a light permeability which is translated by a "leak" in FL2, ie an increase in autofluorescence with the appearance of false positive cells.
On a opéré comme à l'exemple 4, mais avec des conjugués Anticorps anti-CD19-phycoérythrine-texas red. Les résultats sont donnés à la figure 2.We operated as in Example 4, but with conjugates Anti-CD19-phycoerythrin-texas red antibodies. The results are given to the figure 2.
L'analyse des résultats conduit aux mêmes conclusions qu'à l'exemple 4.Analysis of the results leads to the same conclusions as Example 4.
Claims (7)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0016445A FR2818254B1 (en) | 2000-12-15 | 2000-12-15 | PACKAGING FOR PHOTOSENSITIVE COLORANTS |
FR0016445 | 2000-12-15 |
Publications (3)
Publication Number | Publication Date |
---|---|
EP1215135A1 true EP1215135A1 (en) | 2002-06-19 |
EP1215135A8 EP1215135A8 (en) | 2002-09-11 |
EP1215135B1 EP1215135B1 (en) | 2010-11-17 |
Family
ID=8857759
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP01430036A Expired - Lifetime EP1215135B1 (en) | 2000-12-15 | 2001-12-05 | Bottle for photosensitive dyes |
Country Status (9)
Country | Link |
---|---|
US (1) | US6686004B2 (en) |
EP (1) | EP1215135B1 (en) |
JP (1) | JP4421154B2 (en) |
AT (1) | ATE488451T1 (en) |
AU (1) | AU780749B2 (en) |
DE (1) | DE60143468D1 (en) |
ES (1) | ES2353270T3 (en) |
FR (1) | FR2818254B1 (en) |
NZ (1) | NZ516118A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105819108A (en) * | 2016-05-18 | 2016-08-03 | 万臣塑料制品(上海)有限公司 | Color changing package bottle manufacturing technology for daily chemical product industry and product |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2818254B1 (en) * | 2000-12-15 | 2003-02-28 | Immunotech Sa | PACKAGING FOR PHOTOSENSITIVE COLORANTS |
FR2994740B1 (en) * | 2012-08-21 | 2015-03-27 | Horiba Abx Sas | METHOD FOR COMPENSATING THE AGING OF A REAGENT DURING FLUORESCENCE MEASUREMENTS ON PARTICLES, AND BIOLOGICAL ANALYSIS DEVICE IMPLEMENTING THE METHOD |
US9583364B2 (en) | 2012-12-31 | 2017-02-28 | Sunedison Semiconductor Limited (Uen201334164H) | Processes and apparatus for preparing heterostructures with reduced strain by radial compression |
CN113416022B (en) * | 2021-06-30 | 2022-04-26 | 西安中核核仪器股份有限公司 | Gamma detector energy response compensation material and use method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2086342A (en) * | 1980-10-14 | 1982-05-12 | Raffinage Cie Francaise | Multilayer Containers |
JPH05127526A (en) * | 1991-11-06 | 1993-05-25 | Mita Ind Co Ltd | Toner container |
US6117506A (en) * | 1994-03-30 | 2000-09-12 | Silgan Plastics Corporation | Multilayer bottle with encapsulated dark layer |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5110643A (en) * | 1987-01-23 | 1992-05-05 | Fuji Photo Film Co., Ltd. | Packaging material for photosensitive materials |
US5750226A (en) * | 1994-03-02 | 1998-05-12 | Abbott Laboratories | Light excluding multi-layer plastic barrier bottle |
FR2818254B1 (en) * | 2000-12-15 | 2003-02-28 | Immunotech Sa | PACKAGING FOR PHOTOSENSITIVE COLORANTS |
FR2830253B1 (en) * | 2001-09-28 | 2005-02-04 | Air Liquide | NOVEL PROCESS FOR THE PREPARATION OF C-FUNCTIONALIZED NITROGEN MACROCYCLES AND NOVEL INTERMEDIATES OBTAINED |
-
2000
- 2000-12-15 FR FR0016445A patent/FR2818254B1/en not_active Expired - Lifetime
-
2001
- 2001-12-05 EP EP01430036A patent/EP1215135B1/en not_active Expired - Lifetime
- 2001-12-05 DE DE60143468T patent/DE60143468D1/en not_active Expired - Lifetime
- 2001-12-05 AT AT01430036T patent/ATE488451T1/en not_active IP Right Cessation
- 2001-12-05 ES ES01430036T patent/ES2353270T3/en not_active Expired - Lifetime
- 2001-12-12 AU AU97198/01A patent/AU780749B2/en not_active Expired
- 2001-12-13 NZ NZ516118A patent/NZ516118A/en unknown
- 2001-12-17 JP JP2001383093A patent/JP4421154B2/en not_active Expired - Fee Related
- 2001-12-17 US US10/015,938 patent/US6686004B2/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2086342A (en) * | 1980-10-14 | 1982-05-12 | Raffinage Cie Francaise | Multilayer Containers |
JPH05127526A (en) * | 1991-11-06 | 1993-05-25 | Mita Ind Co Ltd | Toner container |
US6117506A (en) * | 1994-03-30 | 2000-09-12 | Silgan Plastics Corporation | Multilayer bottle with encapsulated dark layer |
Non-Patent Citations (3)
Title |
---|
GLAZER ET AL., BIOPHYS. J., vol. 83, 1983, pages 383 - 386 |
LANIER ET AL., METHODS, vol. 2, no. 3, 1991, pages 192 - 199 |
PATENT ABSTRACTS OF JAPAN vol. 017, no. 498 (P - 1609) 8 September 1993 (1993-09-08) * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105819108A (en) * | 2016-05-18 | 2016-08-03 | 万臣塑料制品(上海)有限公司 | Color changing package bottle manufacturing technology for daily chemical product industry and product |
Also Published As
Publication number | Publication date |
---|---|
AU9719801A (en) | 2002-06-20 |
AU780749B2 (en) | 2005-04-14 |
ATE488451T1 (en) | 2010-12-15 |
JP2002234581A (en) | 2002-08-20 |
NZ516118A (en) | 2003-04-29 |
US20020127356A1 (en) | 2002-09-12 |
US6686004B2 (en) | 2004-02-03 |
DE60143468D1 (en) | 2010-12-30 |
EP1215135A8 (en) | 2002-09-11 |
JP4421154B2 (en) | 2010-02-24 |
EP1215135B1 (en) | 2010-11-17 |
ES2353270T3 (en) | 2011-02-28 |
FR2818254A1 (en) | 2002-06-21 |
FR2818254B1 (en) | 2003-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jamin et al. | Chemical heterogeneity in cell death: combined synchrotron IR and fluorescence microscopy studies of single apoptotic and necrotic cells | |
JP2021193111A5 (en) | ||
Chen et al. | Quantum Dot‐mediated Photoproduction of Reactive Oxygen Species for Cancer Cell Annihilation | |
EP1215135B1 (en) | Bottle for photosensitive dyes | |
EP2964724B1 (en) | Plastic scintillator materials, plastic scintillators comprising such materials and method for distinguishing neutrons from gamma rays using said scintillators | |
FR2465311A1 (en) | FLUORESCENT BRONZER LAMP | |
RU2005130528A (en) | FILM CONTAINING ABSORBED LIQUID, METHOD FOR PRODUCING IT AND PRODUCT | |
FR2966044A1 (en) | METHOD FOR CONDITIONING A VACCINE CONTAINING AN ALUMINUM ADJUVANT | |
EP0771734A1 (en) | Liquid dispensing bottle with a permeable membrane | |
FR2491825A1 (en) | MULTILAYER WALL CONTAINER | |
Khmelinskii et al. | Intermediate filaments in the retinal Müller cells as natural light energy guides | |
EP0418335B1 (en) | Process for the evaluation of the anti-oxidant activity of a chemical or physical agent by means of free radicals | |
BRPI0609480A2 (en) | ophthalmic lens inspection methods | |
Masuda et al. | Experimental evidence of distance-dependent diffusion coefficients of a globular protein observed in polymer aqueous solution forming a network structure on nanometer scale | |
Rahmanzadeh et al. | Two ways to inactivate the Ki‐67 protein—Fragmentation by nanoparticles, crosslinking with fluorescent dyes | |
FR2951388A1 (en) | SELECTIVE COLORING PROCESS | |
CA2498239A1 (en) | Use of an organic compound for absorbing ionizing radiation | |
Yamashita et al. | Clarification of degradation mechanism on retinal prosthesis using photoelectric dyes coupled to polyethylene film by mass spectrometry | |
Quintin | Qui a découvert la fluorescence X? | |
FR3042690A1 (en) | DEVICE AND METHOD FOR ENCAPSULATION OF FRAGRANCE SAMPLES OR OTHER LIQUIDS | |
FR2855455A1 (en) | METHOD FOR DECORATING A SUPPORT INCLUDING A TRANSPARENT OUTER LAYER | |
FR2817969A1 (en) | DEVICE AND METHOD FOR IMMUNOLOGICAL ANALYSIS | |
Chundoo | Synthesis and evaluation of nanoparticle-polymer composites | |
FR2720508A1 (en) | A method of demonstrating an analyte in a sample and a device for carrying out the method | |
Meiklejohn et al. | 5-Iodonaphthyl-1-azide labeling of plasma membrane proteins adjacent to specific sites via energy transfer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: DAZIANO, JEAN-PIERRE Inventor name: VAN AGTHOVEN, ANDRE |
|
AKX | Designation fees paid |
Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
17P | Request for examination filed |
Effective date: 20030102 |
|
17Q | First examination report despatched |
Effective date: 20090206 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REF | Corresponds to: |
Ref document number: 60143468 Country of ref document: DE Date of ref document: 20101230 Kind code of ref document: P |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Effective date: 20110216 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: VDEP Effective date: 20101117 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110317 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101117 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101117 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101117 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101117 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101117 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FD4D |
|
BERE | Be: lapsed |
Owner name: IMMUNOTECH Effective date: 20101231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110218 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101231 Ref country code: IE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101117 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101117 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101231 |
|
26N | No opposition filed |
Effective date: 20110818 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101231 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101231 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 60143468 Country of ref document: DE Effective date: 20110818 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101117 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20120220 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101206 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101205 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101117 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 15 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 16 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 17 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20201112 Year of fee payment: 20 Ref country code: DE Payment date: 20201124 Year of fee payment: 20 Ref country code: GB Payment date: 20201125 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20210108 Year of fee payment: 20 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 60143468 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 Expiry date: 20211204 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20211204 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20220405 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20211206 |